@TheLoreOfHiking Many would regard gilenya (fingolimod) as the most effective based on its superiority in a head-to-head trial against avonex, though this is debatable. For more info on efficacy and safety data of the 3 meds, take a look at this article:
@MilenaOkic @Brandon_Beaber Before You talk Read https://t.co/VYd00y1TkC https://t.co/OuuTji9aAZ https://t.co/Dld1oy9JWd The ones that do help will have huge risks involved.
RT @MltplSclppr: Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis. https://t.co…
Comparison of efficacy and safety of oral agents for relapsing-remitting multiple sclerosis. - PubMed - NCBI https://t.co/fdOlHE3fnJ
RT @MltplSclppr: Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis. https://t.co…
Comparison of efficacy and safety of oral agents for the treatment of Multiple Sclerosis #MS https://t.co/dJJ6ejdQfz https://t.co/y1Z6tczqnm
Comparison of efficacy and safety of oral agents for the treatment of relapsing-remitting multiple sclerosis. https://t.co/RDW1eHnLg9